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ABSTRACT
Objective: The role of adipose tissue as an endocrine organ is of great interest and leptin seems to be involved in it. The aim of this study is to 
document the characteristic of participants with respect to leptin and body mass index (BMI), with both parental history of central obesity and to 
describe the association in it.
Methods: This was a cross-sectional study. The participants fulfilling the criteria were chosen for the study. 83 patients with both parents obese and 
55 participants with both parents normal were selected for the study. The participants were divided into four groups based on their status of diabetes 
and family history of central obesity.
Results: Leptin values obtained was higher in those patients with both parental history of central obesity with a mean difference of 11.1 units 
(p<0.001) in diabetic patients and 6.44 units (p<0.001) among the normal participants though BMI showed no much difference between the groups.
Conclusion: The data of this study demonstrated the genetic relationship between leptin levels and obesity.
Hence family history information serve as an useful tool in public health and prevention efforts needs to be extended to members who are at risk of 
developing the complications associated with it.
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INTRODUCTION
The adult onset of diabetes in aged 20-70 years is expected to rise from 
285 million in 2010 to 438 million by the year 2030 [1]. Furthermore, 
obesity has become the strongest risk factors for developing type 2 
diabetes (T2D) and is a major clinical problem. The global scenario in 
the prevalence, incidence, mortality, and burden of obesity and other 
adverse health conditions has alarmingly raised among the adults. 
Hence, obesity is now the world’s most prevalent disorder. Recent 
reports show alarming rise in T2D in all ethnicity along with the rise 
in obesity. This striking increase in obesity and diabetes is prevalent 
in both adolescents and children [2,3]. Obesity is one of the leading 
causes of metabolic syndrome and has become an international 
concern for health risk [4]. The constellation of derangements of the 
metabolic pathway has associated with it a group of disorders. In 
2014, 39% of adults aged 18 years and above (38% of men and 40% 
of women) were overweight. The worldwide prevalence of obesity 
was more than doubled between 1980 and 2014 [5]. The prevalence 
of obesity rose from 2% to 17.1% [6], and as per the National Family 
Health Survey (NFHS) in Karnataka, the percentage of women aged 
15-49 years who were overweight or obese (body mass index [BMI] 
≥25.0 kg/m2) increased from 15% in (2005-06) NFHS-3 to 23% (2015-
16) in NFHS-4 [7]. Similarly, in men who are overweight or obese (BMI 
≥25.0 kg/m2) with a similar age has increased from 11% in (2005-
06) NFHS-3 to 22% in (2015-16) NFHS-4 [8]. Despite the significant 
understanding of the environmental and genetic factors, its prevalence 
seems to rise. Although studies suggest lifestyle modification, dietary 
interventions, and weight loss to be reasonably as health protective 
barriers for the risk of T2D, little is known about the other prevention 
strategies. Genetic factors and the susceptible genes have been 
identified, but the results are not guaranteed. Since diabetes is a chronic 
disease, there is a long time between the exposure and existence 
of clinical features of it. Further family history reflects hereditary 
component and henceforth an heritable factor[9-15], an knowledge 
into assessing of family history as a public health tool would be an 
easy approach in prevention and progress of the risk factor associated. 
Guidelines from associations and education programs now consider 
in including family history as a factor in health behavior [16-18] since 
inherited factors are important in obesity. The central control of energy 
balance and fat mass is leptin an adipocyte hormone. The adiposity 
signal to the brain by leptin must also be inherited in due course. Hence, 
a distinguishable marker for obesity-related diabetes should be used as 
a standard operational definition for family history. The objective of this 
study was to investigate the importance of parental history of obesity 
in diabetic and healthy controls with the leptin profiles in participants 
with similar BMI.
METHODS
This was a cross-sectional study conducted in Dakshina Kannada 
district of Karnataka with 229 cases of T2D patients, matched with 205 
healthy individuals as the control.
The participants aged between 30 and 70 years (both genders) were 
recruited for the study. The inclusion criteria for the patients were known 
case of T2D for at least 1 year, can be only on oral hypoglycemic drugs 
or diet control, free from any of the vascular disorders such as diabetic 
nephropathy, neuropathy, and retinopathy. The study participants 
must also be free from any pre-existing cardiovascular disease, non-
pregnant females, and females free from usage of any hormones or 
oral contraceptives. Self-reported history of presence or absence of 
central obesity in both the parents was obtained. Parents who did not 
appear to have central obesity and with a lean body were considered as 
negative controls and with central obesity were considered as positive 
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controls, and such participants were selected and grouped. Of the initial 
229 cases of diabetic patients, 83 were eligible for the participation and 
were able to report their parental history of obese or lean stature. Out of 
205 healthy individuals, 55 were eligible and participated. Hence, two 
groups were created in both diabetic and healthy people. Participants 
with the parents having central obesity were grouped as two plus (++) 
and without central obesity were grouped as two minus (−−). Relevant 
examination was done to establish the inclusion and exclusion criteria. 
Clinical examination of pulse beats/minute, blood pressure, and stress 
test (TMT) was done for the assessment of cardiovascular system, and 
scan of abdominal system was done.
Diabetic neuropathy was ruled out by filament test and quantitative 
sensory testing (QST). In our study, we have used 10-g monofilament to 
find the sensation to the filament. Loss of sensation to this is considered 
as positive for diabetic neuropathy. QST is used to evaluate a sensory 
detection threshold or other sensory responses from supra-threshold 
stimulation. The common physical stimuli were (i) touch-pressure, 
(ii) vibration, and (iii) coolness, warmth, cold pain, and heat pain. Failure 
to identify these was considered positive for diabetic neuropathy.
Ophthalmoscope (fundoscopy) is used to diagnose diabetic retinopathy 
during a dilated eye exam. It is done as a part of an eye examination or 
routine physical examination. It is crucial in determining the health of 
the retina and the vitreous humor. A positive case was not included in 
the study.
Microalbuminuria: Spot-check samples were used along with the 
albumin/creatinine ratio (ACR). Any participants with ACR ≥3.5 mg/
mmol (female) or ≥2.5 mg/mmol (male) was excluded.
Cardiac stress test (or cardiac diagnostic test) was used to rule out any 
pre-existing cardiovascular disease (CVD). Here, the stress response 
is induced by exercise. Walking on a treadmill, any diagnosis of CVD 
would rule out the criteria as a participant for the study. Work was 
approved by Yenepoya University ethics committee. Written informed 
consent was obtained from the selected participants. 5 ml of blood in 
the fasting state was drawn, and the separated serum was stored at 
−30°C in the Department of Biochemistry, Yenepoya Medical College 
and was used within 45 days for the estimation of Leptin with Ray 
biotech kit using ELISA instrument at the Department of Biochemistry, 
Yenepoya Medical College.
Anthropometric variables such as height and weight were measured 
as per the standard procedure. Measurements of the weight to the 
nearest 0.1 kg by a weighing machine and height to the nearest of 
0.1 cm by an anthropometer rod were done. BMI was calculated as 
weight (kg)/height (m2).
Statistical analysis: The values were expressed as Mean ± standard 
deviation. All the data were analyzed applying two sample t-test. The 
hypotheses of equal means were tested at 5% level of significance. The 
results were analyzed using SPSS version 15.0.
RESULT
The general characteristics of the diabetic study group and its 
comparison(corrected for unequal variance) are shown in Table 1. 
Clearly the leptin levels are increased in subjects with 11.1 units with 
both parents being obese and the difference was statistically significant 
though the difference in their BMI was not significant.
Table 2 shows the general characteristics of the Normal subjects of 
the study group and its comparison(corrected for unequal variance). 
Subjects with obese parents  had a higher leptin levels by 6.4 units even 
when the BMI showed no variations. 
Figure 1 shows levels of leptin among the two study groups. Diabetic 
subjects had a higher level of leptin when compared to the normal 
subjects. Also when family history of obesity was present, a higher level 
of leptin was noticed. 
Figure 2 shows the levels of BMI amoung the group. The BMI among the 
study population did not vary much  inspite of family history of obesity. 
DISCUSSION
Obesity is considered as a serious health complication. Since obesity is 
linked with high levels of circulating free fatty acid, eventually leading 
to the progression of insulin resistance, diabetes, and cardiovascular 
disease. Obesity reflects interaction of genes, environment, and 
lifestyle. Familial aggregation is one of the strong reasons for increased 
prevalence of obesity and its associated disorder. The parent-child 
resemblance in body weight status is now an important factor to be 
considered hence the need of this study. Multiple studies have suggested 
to have an association between maternal obesity being the cause with 
the increase in body weight of the offsprings [19-21]. Studies show that 
maternal obesity before pregnancy is linked with bigger fetal growth 
during late gestation [22] and postnatal development [19], but in this 
study, this has become the limitation since we were not able to get the 
maternal history during pregnancy. Furthermore, children with obese 
parents have shown to have more risk associated than those with no 
obese parents [23-26], one reason being common raising environment, 
which is true in our study with the finding that a good number of 
patients in our study population had obese parents which eventually 
resulted in diabetes. This is because the appetitive traits and familial 
risk factors are associated with each other. Moreover, the mechanism 
Fig. 1: Levels of leptin among the groups
Fig. 2: Levels of body mass index among the groups
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may be genetic or environmental. This shows that parental obesity 
does interact with the physique and the appetitive traits. Studies by 
Stunkard and Schachter’s speculated that heavier - individuals are to 
be less sensitive to satiety feeling and more responsive to the presence 
of food [27,28]. Furthermore, children of heavier parents differ much 
in their satiety cues and also physical activity [29,30], the mechanistic 
explanations is that the susceptible genes might have been transferred 
onto their off spring’s which is apparent in this study.
In relation to this, studies have documented the effect of the adipokines to 
be involved in the energy regulation and implicated in its pathogeneses 
related disorders. The secretion of an adipokine in relation to this role 
is leptin which has multiple roles in carbohydrate and lipid metabolism, 
reproductive system, and inflammatory and immune reactions [31]. 
The study of leptin interaction with other cytokine is well established. 
It has become a surrogate marker for atherogenic index, prevalence of 
metabolic syndrome, intima-media thickness of the common carotid 
artery, and others [32-35]. Hence, in our study, we observe a higher 
leptin level (Fig. 1) in patients with both parents obese. This explains 
the mechanism underlying the associations between parental obesity 
and associated risk factors along with diabetes.
It is a well-known fact that circulating leptin levels are well associated 
with the degree of adiposity. However, it is of considerable interest to 
note that our study population had similar BMI (Fig. 2) which implies 
the presence of similar adiposity. The major findings in our studies are 
that though with similar adiposity, families with both parents obese 
had a higher level of leptin than with those without which rules out 
the interference of being common raising environment effects. Hence, 
a secondary regulator is implied in its action which is hereditary factor.
CONCLUSION
We have substantiated that genetic and adiposity relationship does 
exist and the biological mechanism to which it contributes to the 
genetic dependent regulation of leptin levels in humans have yet to be 
elucidated. These areas are clearly the potential topic of future research.
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Table 1: General characteristics of diabetic subjects with 
parental  history of  central obesity










Leptin (ng/ml) 24.1±7.79 12.69±0.57 10.07* <0.001
BMI (kg/m2) 29.35±5.12 28.75±4.50 0.54 0.59 NS
*Equal variance not assumed, corrected for unequal variance. SD: Standard 
deviation, NS: Not significant, BMI: Body mass index
Table 2: General characteristics of normal subjects with 
parental history of central obesity










Leptin (ng/ml) 17.60±5.31 11.16±1.09 6.3* <0.001
BMI (kg/m2) 28.7±3.56 27.33±3.91 1.46 0.15 NS
*Equal variance not assumed, corrected for unequal variance. SD: Standard 
deviation, NS: Not significant, BMI: Body mass index
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